Cost and Utilization Outcomes After Exclusion of Dipeptidyl...

Cost and Utilization Outcomes After Exclusion of Dipeptidyl Peptidase-4 Inhibitors and Other Diabetes Drug Category Changes in a Self-Funded, State Employee Managed Care Plan

King, Jarrod, McAdam-Marx, Carrie, McCaleb, Rachael, Davis, Dwight, Bemberg, Geri Beth, Johnson, Jill T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Journal of Managed Care & Specialty Pharmacy
DOI:
10.18553/jmcp.2019.25.6.646
Date:
June, 2019
File:
PDF, 186 KB
english, 2019
Conversion to is in progress
Conversion to is failed